can t sleep on glp 1 OZEMPIC/MOUNJARO USERS: Why Problems Happen & What to Do // Dr. G Explains GLP‑1 medications do more than

This was the first instance of ADA guidelines outlining the use of GLP-1 receptor agonists in patients with T2DM with ASCVD or risk factors for ASCVD

We aimed to explore changes in body weight, cardiometabolic and endocrine parameters in obese women with PCOS who continued metformin treatment 2 years after semaglutide cessation

A 40-week clinical trial involving 1,800 participants compared type 2 diabetes treatment with tirzepatide and semaglutide and found similar results

This is worth discussing with your provider to rule out other causes

Conclusions With the increase in the DM medications at the clinicians disposal comes an even greater responsibility to carry out more robust scrutiny and customized T2D management